The RBD residues that interacted with IVM were found to be hotspot residues in the RBD-ACE2 complex, showing that IVM might be able to interrupt the SARS-CoV-2 infection in human cells which makes IVM a potential prevention and treatment of COVID-19. Here, ACE2 is linked to COVID-19.